| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Carlota Menéndez-Pérez, Rafael Rivas-Santisteban, Eva Del Valle, Jorge Tolivia, Ana Navarro, Rafael Franco, Eva Martínez-Pinill. Heteromers Formed by GPR55 and Either Cannabinoid CB International journal of molecular sciences. vol 25. issue 8. 2024-04-27. PMID:38673761. |
heteromers formed by gpr55 and either cannabinoid cb multiple sclerosis (ms) is an autoimmune, inflammatory, and neurodegenerative disease of the central nervous system for which there is no cure, making it necessary to search for new treatments. |
2024-04-27 |
2024-04-29 |
Not clear |
| Amin Najafi, Negin Ashoori, Katayoon Hosseini, Vahid Abbas. Optical coherence tomography in multiple sclerosis. Medical hypothesis, discovery & innovation ophthalmology journal. vol 12. issue 4. 2024-04-11. PMID:38601055. |
multiple sclerosis (ms) is a chronic neurodegenerative disease that damages myelinated fibers within the central nervous system. |
2024-04-11 |
2024-04-13 |
human |
| Livia Guadalupi, Georgia Mandolesi, Valentina Vanni, Sara Balletta, Silvia Caioli, Anto Pavlovic, Francesca De Vito, Diego Fresegna, Krizia Sanna, Laura Vitiello, Monica Nencini, Alice Tartacca, Fabrizio Mariani, Valentina Rovella, Sven Schippling, Iris Ruf, Ludovic Collin, Diego Centonze, Alessandra Musell. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis. Neuropharmacology. 2024-04-03. PMID:38570068. |
the endocannabinoid system (ecs) is critically involved in the pathophysiology of multiple sclerosis (ms), a neuroinflammatory and neurodegenerative disease of the central nervous system (cns). |
2024-04-03 |
2024-04-06 |
mouse |
| Esmaeil Yazdanpanah, Sepehr Dadfar, Alireza Shadab, Niloufar Orooji, MohammadHossein Nemati, Alireza Pazoki, Seyed-Alireza Esmaeili, Rasoul Baharlou, Dariush Haghmora. Berberine: A natural modulator of immune cells in multiple sclerosis. Immunity, inflammation and disease. vol 12. issue 3. 2024-03-13. PMID:38477663. |
multiple sclerosis (ms) is a chronic disabling and neurodegenerative disease of the central nervous system (cns) characterized by the recruitment of autoreactive t cells into the cns causing demyelination, axonal damage, and oligodendrocyte loss. |
2024-03-13 |
2024-03-15 |
Not clear |
| Marios Lemonaris, Kleopas A Kleop. Highly Active Relapsing-Remitting Multiple Sclerosis with Neurofibromatosis Type 1: Radiological Aspects and Therapeutic Challenges - Case Report. Case reports in neurology. vol 16. issue 1. 2024-02-26. PMID:38405018. |
multiple sclerosis (ms) is an autoimmune neurodegenerative disease which can rarely co-exist with neurofibromatosis 1 (nf1), a neurocutaneous inherited disorder that predisposes to oncogenesis. |
2024-02-26 |
2024-02-28 |
Not clear |
| Gina Shim, Alejandra I Romero-Morales, Srinidhi R Sripathy, Brady J Mahe. Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders. Frontiers in cellular neuroscience. vol 17. 2024-01-26. PMID:38273973. |
oligodendrocyte dysfunction and/or dysmyelination can contribute to a range of neurodegenerative diseases and neuropsychiatric disorders such as multiple sclerosis (ms), leukodystrophy (ld), schizophrenia (scz), and autism spectrum disorder (asd). |
2024-01-26 |
2024-01-28 |
human |
| b' Mar\\xc3\\xada Cuerda-Ballester, Antonio Bustos, David Sancho-Cantus, David Mart\\xc3\\xadnez-Rubio, Jes\\xc3\\xbas Privado, Jorge Alarc\\xc3\\xb3n-Jim\\xc3\\xa9nez, Carlos Villar\\xc3\\xb3n-Casales, Nieves de Bernardo, Esther Navarro Illana, Jos\\xc3\\xa9 Enrique de la Rubia Ort\\xc3\\xa. Predictive Model of Anxiety and Depression Perception in Multiple Sclerosis Patients: Possible Implications for Clinical Treatment. Bioengineering (Basel, Switzerland). vol 11. issue 1. 2024-01-26. PMID:38275580.' |
multiple sclerosis (ms) is a neurodegenerative disease characterized by motor and non-motor symptoms, including emotional distress, anxiety, and depression. |
2024-01-26 |
2024-01-28 |
Not clear |
| Wenxin Wang, Tao Su. Impact of TRPV1 on Pathogenesis and Therapy of Neurodegenerative Diseases. Molecules (Basel, Switzerland). vol 29. issue 1. 2024-01-11. PMID:38202764. |
recent studies have shown the strong pathogenetic associations of trpv1 with neurodegenerative diseases (nds), in particular alzheimer's disease (ad), parkinson's disease (pd) and multiple sclerosis (ms) via regulating neuroinflammation. |
2024-01-11 |
2024-01-13 |
Not clear |
| Rozhin Dabbaghi, Reza Safaralizadeh, Shima Rahmani, Nesa Barpour, Mohammadali Hosseinpourfeizi, Ali Rajabi, Behzad Baradara. The effect of glatiramer acetate, IFNβ-1a, fingolimod, and dimethyl fumarate on the expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS patients. BMC research notes. vol 16. issue 1. 2023-10-16. PMID:37845751. |
multiple sclerosis (ms) is a progressing neurodegenerative disease marked by chronic central nervous system inflammation and degeneration.this study investigates gene expression profiles of t-box transcription factor tbx21 (t-bet), interferon-gamma (ifn-γ), and long non-coding rna meg3 in peripheral blood mononuclear cells (pbmcs) from treatment-naïve relapsing-remitting multiple sclerosis patients (rrms), healthy controls, and rrms patients on different disease modifying therapies (dmts). |
2023-10-16 |
2023-11-08 |
Not clear |
| Victor Voicu, Felix-Mircea Brehar, Corneliu Toader, Razvan-Adrian Covache-Busuioc, Antonio Daniel Corlatescu, Andrei Bordeianu, Horia Petre Costin, Bogdan-Gabriel Bratu, Luca-Andrei Glavan, Alexandru Vlad Ciure. Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy. Biomolecules. vol 13. issue 9. 2023-09-28. PMID:37759788. |
special emphasis is placed on the role of cannabinoids in neurodegenerative diseases, showcasing their potential benefits in conditions such as alzheimer's disease, parkinson's disease, huntington's disease, and multiple sclerosis. |
2023-09-28 |
2023-10-07 |
human |
| Alessia d'Arma, Annalisa Valle, Davide Massaro, Gisella Baglio, Sara Isernia, Sonia Di Tella, Marco Rovaris, Francesca Baglio, Antonella Marchett. A cultural training for the improvement of cognitive and affective Theory of Mind in people with Multiple Sclerosis: a pilot randomized controlled study. Frontiers in psychology. vol 14. 2023-09-08. PMID:37680245. |
theory of mind (tom), the ability to understand and attribute mental states to ourselves and others, could be impaired in multiple sclerosis (ms), a neurodegenerative disease affecting young adults. |
2023-09-08 |
2023-10-07 |
human |
| Adedeji O Adenusi, Hezborn M Magacha, Chisom M Nwaneki, Olamide A Asifat, Eugene N Anno. Cannabis Use and Associated Gastrointestinal Disorders: A Literature Review. Cureus. vol 15. issue 7. 2023-08-14. PMID:37575784. |
it is widely used for recreational purposes, while its therapeutic benefits have been extensively explored in the us. for several years, cannabis has been used for the treatment of diverse health conditions, including pain management, anti-inflammatory effects, and spasticity associated with multiple sclerosis and other neurodegenerative diseases. |
2023-08-14 |
2023-08-16 |
Not clear |
| Michael Hecker, Brit Fitzner, Nina Boxberger, Elena Putscher, Robby Engelmann, Wendy Bergmann, Michael Müller, Isis Ludwig-Portugall, Margit Schwartz, Stefanie Meister, Ales Dudesek, Alexander Winkelmann, Dirk Koczan, Uwe Klaus Zett. Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy. Journal of neuroinflammation. vol 20. issue 1. 2023-08-02. PMID:37533036. |
multiple sclerosis (ms) is a chronic, inflammatory and neurodegenerative disease that leads to irreversible damage to the brain and spinal cord. |
2023-08-02 |
2023-08-14 |
Not clear |
| Yoav Piura, Arnon Karni, Hadar Kolb, Ifat Vigiser, Keren Rege. Olfactory function in Susac syndrome. Clinical neurology and neurosurgery. vol 233. 2023-07-31. PMID:37524045. |
olfactory dysfunction is a common early manifestation of several central nervous system diseases, including neurodegenerative diseases and autoimmune-mediated diseases such as multiple sclerosis. |
2023-07-31 |
2023-08-14 |
Not clear |
| Matilda Iemmolo, Giulio Ghersi, Giulia Bivon. The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases. International journal of molecular sciences. vol 24. issue 9. 2023-05-14. PMID:37175729. |
in this review, the dual roles of cx3cl1 and adams/mmps in different neurodegenerative diseases, such as alzheimer's disease (ad), parkinson's disease (pd), huntington's disease (mh), and multiple sclerosis (ms), are investigated. |
2023-05-14 |
2023-08-14 |
Not clear |
| Alba Ordoñez-Rodriguez, Pablo Roman, Lola Rueda-Ruzafa, Ana Campos-Rios, Diana Cardon. Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review. International journal of environmental research and public health. vol 20. issue 5. 2023-03-11. PMID:36901634. |
multiple sclerosis (ms) is a chronic inflammatory neurodegenerative disease mediated by autoimmune reactions against myelin proteins and gangliosides in the grey and white matter of the brain and spinal cord. |
2023-03-11 |
2023-08-14 |
Not clear |
| Yousra El Ouaamari, Jasper Van den Bos, Barbara Willekens, Nathalie Cools, Inez Wen. Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives. International journal of molecular sciences. vol 24. issue 4. 2023-02-25. PMID:36835277. |
neurodegenerative diseases, including alzheimer's disease (ad), parkinson's disease (pd), huntington's disease (hd), multiple sclerosis (ms), spinal cord injury (sci), and amyotrophic lateral sclerosis (als), are characterized by acute or chronic progressive loss of one or several neuronal subtypes. |
2023-02-25 |
2023-08-14 |
Not clear |
| b' Mar\\xc3\\xada Cuerda-Ballester, David Mart\\xc3\\xadnez-Rubio, Mar\\xc3\\xada Pilar Garc\\xc3\\xada-Pardo, Bel\\xc3\\xa9n Proa\\xc3\\xb1o, Laura Cubero, Antonio Calvo-Capilla, David Sancho-Cantus, Jose Enrique de la Rubia Ort\\xc3\\xa. Relationship of Motor Impairment with Cognitive and Emotional Alterations in Patients with Multiple Sclerosis. International journal of environmental research and public health. vol 20. issue 2. 2023-01-21. PMID:36674140.' |
multiple sclerosis (ms) is a neurodegenerative disease that, despite mainly affecting women, is more severe in men and causes motor, cognitive and emotional alterations. |
2023-01-21 |
2023-08-14 |
Not clear |
| Sienna S Drake, Marc Charabati, Tristan Simas, Yu Kang T Xu, Etienne J P Maes, Shan Shan Shi, Jack Antel, Alexandre Prat, Barbara Morquette, Alyson E Fournie. 3-Dimensional Immunostaining and Automated Deep-Learning Based Analysis of Nerve Degeneration. International journal of molecular sciences. vol 23. issue 23. 2022-12-11. PMID:36499143. |
multiple sclerosis (ms) is an autoimmune and neurodegenerative disease driven by inflammation and demyelination in the brain, spinal cord, and optic nerve. |
2022-12-11 |
2023-08-14 |
mouse |
| Nicole Rychlik, Petra Hundehege, Thomas Budd. Influence of inflammatory processes on thalamocortical activity. Biological chemistry. 2022-12-01. PMID:36453998. |
it is known that the thalamus plays an important role in pathological brain conditions involved in demyelinating, inflammatory and neurodegenerative diseases such as multiple sclerosis (ms). |
2022-12-01 |
2023-08-14 |
Not clear |